Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Pre-cancer”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Not applicableLooking for participantsNCT06371274
What this trial is testing

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Who this might be right for
Triple-negative Breast Cancer
First Affiliated Hospital of Zhejiang University 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783581
What this trial is testing

Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial

Who this might be right for
Locally Advanced Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
Mayo Clinic 30
Testing effectiveness (Phase 2)UnknownNCT05803915
What this trial is testing

Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy

Who this might be right for
Oral Squamous Cell Carcinoma
Peking Union Medical College Hospital 57
Large-scale testing (Phase 3)Ended earlyNCT03475680
What this trial is testing

Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery

Who this might be right for
Colon Cancer
Assistance Publique - Hôpitaux de Paris 193
Testing effectiveness (Phase 2)Study completedNCT01256385
What this trial is testing

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more
National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07095478
What this trial is testing

Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer

Who this might be right for
CIN 2/3
Metanoic Health Ltd. 28
Early research (Phase 1)Study completedNCT01456676
What this trial is testing

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Who this might be right for
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 11
Testing effectiveness (Phase 2)Study completedNCT00524017
What this trial is testing

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Who this might be right for
Head and Neck CancerPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Post-approval studies (Phase 4)Looking for participantsNCT06562543
What this trial is testing

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Who this might be right for
Colorectal Cancer
Takeda 78
Not applicableStudy completedNCT07653737
What this trial is testing

Immunonutrition for Prehabilitation of Patients With Colorectal Cancer Before Surgery

Who this might be right for
Colorectal CancerNutrition Aspect of Cancer
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 56
Testing effectiveness (Phase 2)Study completedNCT00513695
What this trial is testing

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Who this might be right for
Inflammatory Breast CancerMale Breast CancerStage II Breast Cancer+3 more
University of Washington 68
Early research (Phase 1)Study completedNCT00483860
What this trial is testing

A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function

Who this might be right for
Solid Tumours
GlaxoSmithKline 59
Early research (Phase 1)UnknownNCT04477057
What this trial is testing

PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd. 30
Large-scale testing (Phase 3)Ended earlyNCT02730091
What this trial is testing

A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease

Who this might be right for
Breast Cancer
Centre Hospitalier Universitaire de Besancon 98
Early research (Phase 1)Study completedNCT00954226
What this trial is testing

Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer

Who this might be right for
Recurrent Head and Neck CarcinomaRecurrent Salivary Gland CarcinomaRecurrent Skin Carcinoma+1 more
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT03517618
What this trial is testing

TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC

Who this might be right for
Metastatic Colorectal Cancer
TTY Biopharm 41
Very early researchStudy completedNCT03923998
What this trial is testing

Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers

Who this might be right for
Squamous Cell Carcinoma of Oral Cavity
Indrayani Hospital and Cancer Institute 8
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Early research (Phase 1)Study completedNCT02191891
What this trial is testing

Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 32
Testing effectiveness (Phase 2)Ended earlyNCT00573989
What this trial is testing

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 27
Next Page